[Epigenetics and cancer]
- PMID: 15811306
- DOI: 10.1051/medsci/2005214405
[Epigenetics and cancer]
Abstract
Epigenetics is defined as "the study of mitotically and/or meiotically heritable changes in gene expression that cannot be explained by changes in the DNA sequence". Setting up the epigenetic program is crucial for correct development and its stable inheritance throughout its lifespan is essential for the maintenance of the tissue- and cell-specific functions of the organism. For many years, the genetic causes of cancer have hold centre stage. However, the recent wealth of information about the molecular mechanisms which, by modulating the chromatin structure, can regulate gene expression has high-lighted the predominant role of epigenetic modifications in the initiation and progression of numerous pathologies, including cancer. The nucleosome is the major target of these epigenetic regulation mechanisms. They include a series of tightly interconnected steps which starting with the setting ("writing") of the epigenetic mark till its "reading" and interpretation will result in long-term gene regulation. The major epigenetic changes associated with tumorigenesis are aberrant DNA methylation of CpG islands located in the promoter region of tumor suppressor gene, global genomic hypomethylation and covalent modifications of histone N-terminal tails which are protruding out from the nucleosome core. In sharp contrast with genetic modifications, epigenetic modifications are highly dynamic and reversible. The characterization of specific inhibitors directed against some key epigenetic players has opened a new and promising therapeutic avenue, the epigenetic therapy, since some inhibitors are already used in clinical trials.
Similar articles
-
Epigenetic changes in cancer.APMIS. 2007 Oct;115(10):1039-59. doi: 10.1111/j.1600-0463.2007.apm_636.xml.x. APMIS. 2007. PMID: 18042143 Review.
-
[Epigenetics-related diseases and analytic methods].Rinsho Byori. 2009 Aug;57(8):769-78. Rinsho Byori. 2009. PMID: 19764412 Review. Japanese.
-
Interplay between different epigenetic modifications and mechanisms.Adv Genet. 2010;70:101-41. doi: 10.1016/B978-0-12-380866-0.60005-8. Adv Genet. 2010. PMID: 20920747 Review.
-
Epigenetics, disease, and therapeutic interventions.Ageing Res Rev. 2006 Nov;5(4):449-67. doi: 10.1016/j.arr.2006.07.001. Epub 2006 Sep 11. Ageing Res Rev. 2006. PMID: 16965942 Review.
-
The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.J Urol. 2007 Mar;177(3):822-31. doi: 10.1016/j.juro.2006.10.063. J Urol. 2007. PMID: 17296351 Review.
Cited by
-
Impact of local anesthetics on epigenetics in cancer.Front Oncol. 2022 Aug 30;12:849895. doi: 10.3389/fonc.2022.849895. eCollection 2022. Front Oncol. 2022. PMID: 36110954 Free PMC article. Review.
-
DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge.Biomolecules. 2017 Jan 5;7(1):3. doi: 10.3390/biom7010003. Biomolecules. 2017. PMID: 28067760 Free PMC article. Review.
-
The role of histone modifications and variants in regulating gene expression in breast cancer.J Mammary Gland Biol Neoplasia. 2010 Mar;15(1):19-33. doi: 10.1007/s10911-010-9167-z. Epub 2010 Feb 4. J Mammary Gland Biol Neoplasia. 2010. PMID: 20131086 Review.
-
Inhibition of P53-mediated cell cycle control as the determinant in dedifferentiated liposarcomas development.Am J Cancer Res. 2021 Jun 15;11(6):3271-3284. eCollection 2021. Am J Cancer Res. 2021. PMID: 34249461 Free PMC article.
-
Immunological Effects of Epigenetic Modifiers.Cancers (Basel). 2019 Dec 1;11(12):1911. doi: 10.3390/cancers11121911. Cancers (Basel). 2019. PMID: 31805711 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
